Session Information

 x 
My Library Virtual Library FAQ

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

    Switch to Virtual Meeting
    Enter Virtual Meeting Access Code
Filter Results:

Show Only CME Accredited Sessions

  • +

    FP12 - Predictive Tumor Based Assays/Biomarkers/Pathology

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
    • +

      FP12.08 - Lung Adenocarcinomas with ROS1 Rearrangement show Diffuse Strong ROS1 Immunohistochemical Staining

      00:00 - 00:00  |  Presenter: Timothy Fielder

      • Abstract

      Loading...

  • +

    P59 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Targeted Therapies Biomarkers

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
    • +

      P59.12 - KRAS Mutation Subtypes in Non-Small Cell Lung Cancer and Clinical Outcomes: A Single Centre Experience

      00:00 - 00:00  |  Presenter: Alexander Patrick Davis

      • Abstract

      Loading...

  • +

    ES09 - Pathology Assessment and Biomarker Testing: Implications of and for Adjuvant and Neoadjuvant Therapy*

    • 10:30 - 11:05
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES09.01 - Adjuvant and Neoadjuvant Therapy for NSCLC – Current and Future Perspectives

      10:30 - 10:32  |  Presenter: Daniel Tan

      • Abstract

      No abstract available for this presentation

    • +

      ES09.02 - Pathological Assessment Following Neoadjuvant Therapy: Challenges and Pitfalls

      10:32 - 10:34  |  Presenter: Sanja Dacic

      • Abstract

      No abstract available for this presentation

    • +

      ES09.03 - The Role of Biomarkers for Immunotherapy in the Adjuvant and Neoadjuvant Setting

      10:34 - 10:36  |  Presenter: Francois Ghiringhelli

      • Abstract

      Loading...

    • +

      ES09.04 - The Role of Biomarkers for Targeted Therapy in the Adjuvant and Neoadjuvant Setting

      10:36 - 10:38  |  Presenter: Fernando Lopez-Rios

      • Abstract

      No abstract available for this presentation

    • +

      ES09.05 - Facilitating Biomarker Discovery in the Adjuvant and Neoadjuvant Setting

      10:38 - 10:40  |  Presenter: Janis M Taube

      • Abstract

      No abstract available for this presentation

    • +

      ES09.06 - Tobacco Moment: The Criticality of Development of a Validated Tobacco Use Measurement Tool in Clinical Trials (Captured, Considered in Clinical Endpoints and Final Analysis)

      10:40 - 10:43  |  Presenter: Carolyn Dresler

      • Abstract

      No abstract available for this presentation

    • +

      ES09.07 - Live Discussion with Speakers

      10:43 - 11:05

      • Abstract

      No abstract available for this presentation